[May 13, 2013]

Research and Markets: The Global Chiral Technology Market to Grow At A CAGR Of 6.6 Percent over the Period 2012-2016

Research and Markets (http://www.researchandmarkets.com/research/kjb4qz/global_chiral) has announced the addition of the "Global Chiral Technology Market 2012-2016" report to their offering.

One of the key factors contributing to this market growth is favorable government regulations for chiral technology. The Global Chiral Technology market has also been witnessing increasing reliance on generic approaches. However, the slow commercialization of chiral technology-based products could pose a challenge to the growth of this market.

The key vendors dominating this space are Daicel Corp., Chiral Technologies, Royal DSM (News - Alert) N.V., and Sigma Aldrich Corp.

The other vendors mentioned in the report are Albemarle Corp., BASF SE, Cambrex Corp., Chiral Quest Inc., Regis Technologies Inc. and Shasun Pharmaceuticals Ltd.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''The Global Chiral Technology market is witnessing an increase in mergers and acquisitions. Vendors are adopting the mergers and acquisitions strategy to increase their global presence and expand their product portfolio, as well as to achieve economies of scale. Vendors can focus better on product innovations and increase their profit margins by collaborating with each other. For instance, on August 8, 2012, Royal DSM announced that it had entered into an agreement to acquire Tortuga Companhia Zootecnica Agraria, a Brazilian company involved in the manufacturing of nutritional supplements for animals. The increase in such acquisitions boosts the growth of the Global Chiral market.'

Technology market.''

According to the report, the presence of favorable government regulations promoting the use of chiral technology is one of the major drivers of the market. Healthcare authorities across the globe have introduced guidelines and policies to provide incentives and thus encourage investments for the development of single-enantiomer drugs.

Further, the report states that one of the major challenges in the market is the snail-paced commercialization of chiral technology-based drugs and chemicals. This factor has adversely affected the adoption of chiral technology.

For more information visit http://www.researchandmarkets.com/research/kjb4qz/global_chiral

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]